Literature DB >> 2575255

Transdermal delivery of narcotic analgesics: comparative permeabilities of narcotic analgesics through human cadaver skin.

S D Roy1, G L Flynn.   

Abstract

Relationships between the in vitro permeation rates of select narcotic analgesics through human skin and their physicochemical properties were investigated by following the permeation kinetics of six representative compounds in small diffusion cells. The relative permeability coefficients of three phenylpiperidine analogues, meperidine, fentanyl, and sufentanil, all measured on a single piece of skin, were 3.7 x 10(-3), 5.6 x 10(-3), and 1.2 x 10(-2) cm/hr, respectively. Using membranes from the same skin section, the permeability coefficients of three opioid alkaloids, morphine, codeine, and hydromorphone, were considerably lower, at 9.3 x 10(-6), 4.9 x 10(-5), and 1.4 x 10(-5) cm/hr, respectively. The high permeability coefficients of the former compounds are due to their highly lipophilic nature as reflected in high octanol/water partition coefficients and low solubility parameters. Generally, the permeability coefficients of the narcotics increase as the lipophilicity increases. When viewed in literature perspective, the data suggest that aqueous tissue control of transport is approached in the case of the phenylpiperidine analogues, all of which have Koctanol/water values greater than 40. Permeability coefficients of fentanyl and sufentanil were also determined as a function of pH over the pH range 7.4 to 9.4, in this instance with membranes prepared from additional samples of skin. The permeability coefficients of each drug varied less than threefold over the pH range, a behavior consistent with the highly hydrophobic natures of the compounds. The low permeability coefficients of morphine, codeine, and hydromorphone coupled with their low potencies make these drugs poor transdermal candidates. It appears that fentanyl and sufentanil can be successfully transdermally delivered.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2575255     DOI: 10.1023/a:1015944018555

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  28 in total

1.  Determination of morphine and codeine in post-mortem specimens.

Authors:  G R Nakamura; E L Way
Journal:  Anal Chem       Date:  1975-04       Impact factor: 6.986

2.  In vitro and in vivo-release of nitroglycerin from a new transdermal therapeutic system.

Authors:  M Wolff; G Cordes; V Luckow
Journal:  Pharm Res       Date:  1985-01       Impact factor: 4.200

3.  Solubility and related physicochemical properties of narcotic analgesics.

Authors:  S D Roy; G L Flynn
Journal:  Pharm Res       Date:  1988-09       Impact factor: 4.200

4.  Correlation and prediction of mass transport across membranes. II. Influence of vehicle polarity on flux from solutions and suspensions.

Authors:  S H Yalkowsky; G L Flynn
Journal:  J Pharm Sci       Date:  1974-08       Impact factor: 3.534

Review 5.  The practical use of narcotic analgesics.

Authors:  K M Foley
Journal:  Med Clin North Am       Date:  1982-09       Impact factor: 5.456

6.  Postoperative pain relief. Use of an on-demand analgesia computer (ODAC) and a comparison of the rate of use of fentanyl and alfentanyl.

Authors:  B Kay
Journal:  Anaesthesia       Date:  1981-10       Impact factor: 6.955

7.  Percutaneous absorption of alkanoic acids II: Application of regular solution theory.

Authors:  Z Liron; S Cohen
Journal:  J Pharm Sci       Date:  1984-04       Impact factor: 3.534

8.  Penetration of benzene through human skin.

Authors:  I H Blank; D J McAuliffe
Journal:  J Invest Dermatol       Date:  1985-12       Impact factor: 8.551

9.  Solubility behavior of narcotic analgesics in aqueous media: solubilities and dissociation constants of morphine, fentanyl, and sufentanil.

Authors:  S D Roy; G L Flynn
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

10.  The medical approach to management of pain caused by cancer.

Authors:  R B Catalano
Journal:  Semin Oncol       Date:  1975-12       Impact factor: 4.929

View more
  16 in total

1.  Evaluation of analgesic effect and safety of fentanyl transdermal patch for cancer pain as the first line.

Authors:  Yoshiyuki Hoya; Tomoyoshi Okamoto; Katsuhiko Yanaga
Journal:  Support Care Cancer       Date:  2010-03-31       Impact factor: 3.603

Review 2.  Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control.

Authors:  W Jeal; P Benfield
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

3.  Therapeutic dosage assessment based on population pharmacokinetics of a novel single-dose transdermal donepezil patch in healthy volunteers.

Authors:  Hee Youn Choi; Yo Han Kim; Donghyun Hong; Seong Su Kim; Kyun-Seop Bae; Hyeong-Seok Lim
Journal:  Eur J Clin Pharmacol       Date:  2015-05-28       Impact factor: 2.953

Review 4.  Transdermal patches: history, development and pharmacology.

Authors:  Michael N Pastore; Yogeshvar N Kalia; Michael Horstmann; Michael S Roberts
Journal:  Br J Pharmacol       Date:  2015-03-18       Impact factor: 8.739

5.  Evaluation on the reliability of the permeability coefficient (Kp) to assess the percutaneous penetration property of chemicals on the basis of Flynn's dataset.

Authors:  Carolin Kladt; Kathrin Dennerlein; Thomas Göen; Hans Drexler; Gintautas Korinth
Journal:  Int Arch Occup Environ Health       Date:  2018-02-21       Impact factor: 3.015

6.  Transdermal administration of morphine to healthy subjects.

Authors:  D Westerling; P Höglund; S Lundin; P Svedman
Journal:  Br J Clin Pharmacol       Date:  1994-06       Impact factor: 4.335

Review 7.  Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl.

Authors:  S Grond; L Radbruch; K A Lehmann
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

8.  Pharmacokinetics and tolerability of different doses of fentanyl following sublingual administration of a rapidly dissolving tablet to cancer patients: a new approach to treatment of incident pain.

Authors:  B Lennernäs; T Hedner; M Holmberg; S Bredenberg; C Nyström; H Lennernäs
Journal:  Br J Clin Pharmacol       Date:  2005-02       Impact factor: 4.335

9.  Evaluation of skin permeation of β-blockers for topical drug delivery.

Authors:  Doungdaw Chantasart; Jinsong Hao; S Kevin Li
Journal:  Pharm Res       Date:  2012-12-04       Impact factor: 4.200

10.  The role of peripheral mu opioid receptors in the modulation of capsaicin-induced thermal nociception in rhesus monkeys.

Authors:  M C Ko; E R Butelman; J H Woods
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.